Related Experiment Video

Updated: Aug 14, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Doxorubicin (adriamycin) cardiomyopathy

E Saltiel, W McGuire

    The Western Journal of Medicine
    |September 1, 1983
    PubMed

    Insights

    Doxorubicin hydrochloride (Adriamycin) can cause fatal heart damage (cardiomyopathy). This review explores its mechanisms, risk factors, and prevention strategies, including antioxidants and liposomal delivery.

    Area of Science:

    • Cardiology
    • Oncology
    • Pharmacology

    Background:

    • Doxorubicin hydrochloride (Adriamycin) is a vital chemotherapy agent.
    • Its clinical use is restricted by dose-limiting cardiotoxicity, specifically cardiomyopathy.
    • Understanding this toxicity is crucial for improving cancer treatment outcomes.

    Purpose of the Study:

    • To critically review the cardiotoxicity of doxorubicin hydrochloride.
    • To examine the natural history, histopathology, risk factors, and monitoring of this adverse effect.
    • To analyze proposed mechanisms and current prevention strategies.

    Main Methods:

    • Literature review of natural course, histopathology, and risk factors.
    • Analysis of proposed mechanisms of doxorubicin-induced cardiomyopathy.
    • Evaluation of preventive agents and administration methods.

    Main Results:

    • Doxorubicin-induced cardiomyopathy is a significant clinical concern.
    • Mechanisms involve free radical damage, enzyme inhibition, and altered calcium levels.
    • Various agents (e.g., antioxidants, nucleosides) and liposomal delivery show promise for prevention.

    Conclusions:

    • Doxorubicin cardiotoxicity necessitates careful monitoring and risk assessment.
    • Further research into underlying mechanisms can guide the development of effective cardioprotective strategies.
    • Novel delivery systems and pharmacological interventions may mitigate this severe side effect.

    More Related Videos

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    Related Concept Videos

    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...